Details.
Provides product-specific prescription cost-sharing assistance, including up to $13,000 per year for Cabenuva, $7,500 per year for Triumeq, Triumeq PD, and Rukobia, $6,250 per year for Dovato and Juluca, $5,000 per year for Tivicay and Tivicay PD, and $4,800 per year for Lexiva, Selzentry, Ziagen, Trizivir, and Viracept. Cabenuva assistance includes up to $100 per treatment in copay assistance associated with provider administration.